Lawsuits are being filed by people who experienced stomach paralysis (gastroparesis) after taking Ozempic, Mounjaro, and other weight-loss drugs for diabetes
Wegovy Weight Loss Pen: Semaglutide Medication from Denmark Wegovy is a weight-loss pen developed in Denmark, containing the active ingredient Semaglutide
During the first month (weeks 14), mild nausea is frequently caused by appetite suppression
GLP-1 medications are a class of prescription treatments that work with the bodys natural appetite and blood sugar regulation pathways
The greater magnitudes of bodyweight reduction seen in this trial, as well as the improvements in cardiovascular risk factors and glucose control, can have beneficial effects on health goals in clinical practice. In the STEP UP T2D trial, a higher semaglutide dose resulted in an average bodyweight reduction of 13.2%, compared to 10.4% for the standard dose and 3.9% for the placebo